established in 1998 in shenzhen, china, hepalink is a leading multinational biopharmaceutical company dual-listed in hong kong and mainland china, with its core business in heparin industrial chain, large molecule biologics cdmo services, and the research, development, and commercialization of innovative drugs.
these three synergistic business segments are driven by the mission of addressing patients’ unmet medical needs and bringing safe and effective therapies and services to patients around the world.
40business in overcountries and regions
41subsidiariesin regions including
north america and europe
8manufacturing sitesaround the world